Fell V, Hoskins J A, Pollitt R J
Clin Chim Acta. 1978 Feb 15;83(3):259-69. doi: 10.1016/0009-8981(78)90114-6.
Oral doses of L-[2H5]-phenylalanine (25 mg/kg) and L-[2H2]-tyrosine (12.5 mg/kg) were given separately to three normal subjects and together to a fourth. Blood samples were analysed for deuterium labelled phenylalanine and tyrosine, and urine for labelled o-and p-hydroxyphenylacetic, p-hydroxyphenyllactic and p-hydroxymandelic acids. The labelling patterns of the urinary metabolites indicated that the para-compounds all originated in both hepatic and extra-hepatic tissues. The plasma tyrosine did not appear to be in equilibrium with the tyrosine in the liver. It is concluded that a simple quantitative relationship between the labelling of these metabolites and the synthesis of labelled tyrosine from labelled phenylalanine in liver is unlikely.
分别给三名正常受试者口服L-[2H5]-苯丙氨酸(25毫克/千克)和L-[2H2]-酪氨酸(12.5毫克/千克),给第四名受试者同时口服这两种物质。分析血样中的氘标记苯丙氨酸和酪氨酸,分析尿样中的标记邻羟基苯乙酸、对羟基苯乙酸、对羟基苯乳酸和对羟基扁桃酸。尿代谢物的标记模式表明,对位化合物均起源于肝组织和肝外组织。血浆酪氨酸似乎与肝脏中的酪氨酸未达到平衡。得出的结论是,这些代谢物的标记与肝脏中由标记苯丙氨酸合成标记酪氨酸之间不太可能存在简单的定量关系。